Cephalon Inc., founded in 1987 by Frank Baldino Jr., Ph.D., is an international biopharmaceutical speciality company dedicated to the discovery, development and marketing of innovative branded specialty as well as generic products in over 100 countries.
At Cephalon, 4 000 people worldwide are committed to improving patients’ lives.